Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-01-09
2007-01-09
Allen, Marianne P. (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S351000, C530S389200, C435S069520, C424S085200
Reexamination Certificate
active
11010859
ABSTRACT:
The invention provides a method of inducing IL-10 production.
REFERENCES:
patent: 6605699 (2003-08-01), Ni et al.
Zuniga et al., Infect Immun. Nov. 2001;69(11):6804-12.
Abbas et al.Nature, 383:787793 (1996).
Allione et al.J. Immunol., 161:2114-2119 (1998).
Asadullah et al.Pharmacol. Rev., 55(2):241-269 (2003).
Asseman et al.J. Exp. Med., 190(7):995-1003 (1999).
Barondes et al.J. Biol. Chem., 269(33):20807-20810 (1994).
Barondes et al.Cell, 76:597-598 (1994).
Baum et al.Glycoconj. J., 12:63-68 (1995).
Brady et al.Nature, 368:692-693 (1994).
Cho et al.J. Biol. Chem., 270(10):5198-5206 (1995).
Colombel et al.Gut, 49:42-46 (2001).
Davenport et al.Int. Immunopharmacol., 2:653-672 (2002).
Del Prete et al.J. Immunol., 150(2):353-360 (1993).
Dias-Baruffi et al.J. Biol. Chem., 278(42):41282-41293 (2003).
Fedorak et al.Gastroenterol., 119:1473-1482 (2000).
Hara et al.J. Immunol., 166:3789-3796 (2001).
Jameson et al.Nature, 368:744-746 (1994).
Kimball et al.Arch. Dermatol., 138:1341-1346 (2002).
Krensky et al.N. Engl. J. Med., 322(8):510-517 (1990).
Kühn et al.Cell, 75:263-274 (1993).
Leach et al.Am. J. Pathol., 148(5):1503-1515 (1996).
Levi et al.Eur. J. Immunol., 13:500-507 (1983).
Macatonia et al.J. Immunol., 150(9):3755-3765 (1993).
McInnes et al.J. Immunol., 167:4075-4082 (2001).
Offner et al.J. Neuroimmunol., 28:177-184 (1990).
Pace et al.J. Immunol., 163:3801-3811 (1999).
Pace et al.J. Immunol., 165:2331-2334 (2000).
Perillo et al.Nature, 378:736-739 (1995).
Perillo et al.J. Exp. Med., 185(10):1851-1858 (1997).
Powrie et al.Int. Immunol., 5(11):1461-1471 (1993).
Rabinovich et al.J. Exp. Med., 190(3):385-397 (1999).
Rabinovich et al.Immunol., 97:100-106 (1999).
Rabinovich et al.Cell Death Differ., 6:711-721 (1999).
Rabinovich et al.Cell Death Differ., 7:747-753 (2000).
Rabinovich et al.Cell Death Differ., 9:661-670 (2002).
Reich et al.J. Invest. Dermatol., 116:319-329 (2001).
Roncarolo et al.Immunol. Rev., 182:68-79 (2001).
Santucci et al.Hepatol., 31:399-406 (2000).
Santucci et al.Gastroenterol., 124:1381-1394 (2003).
Schlaak et al.J. Invest. Dermatol., 102:145-149 (1994).
Schreiber et al.Gastroenterol., 119:1461-1472 (2000).
Stämpfli et al.Am. J. Respir. Cell Mol. Biol., 21:586-596 (1999).
Stelmach et al.Clin. Exp. Allergy, 32:264-269 (2002).
Takanashi et al.Eur. Respir. J., 14:309-314 (1999).
Tournoy et al.Clin. Exp. Allergy, 30:775-783 (2000).
Van der Leij et al.Transplantation, 75(12):2076-2082 (2003).
Van Deventer et al.Gastroenterol., 113:383-389 (1997).
Velculescu et al.Science, 270:484-487 (1995).
Walzel et al.Immunol. Lett., 67:193-202 (1999).
Walzel et al.Cell. Signal., 14:861-868 (2002).
Baum et al.Clin. Immunol., 109(3):295-307 (2003).
Delioukina et al.Blood, Abstract #1739, 94(10 Supp. 1):392A (1999).
Emmanouilides et al.Blood, Abstract 904, 90(10 Supp. 1):205A (1997).
LiuClin. Immunol., 97(2):79-88 (2000).
Van der Leij et al.J. Pathol., 204(5):511-518 (2004).
International Search Report for PCT IB2004/004437, mailed Oct. 10, 2005.
Groen Herman
Poppema Sibrand
van den Berg Anke
van der Leij Judith
van Weeghel Rob P.
Allen Marianne P.
Elrifi Ivor R.
IQ Corporation BV
Kozakiewicz Cynthia A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Methods of inducing IL-10 production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inducing IL-10 production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inducing IL-10 production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3795229